Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1261-1270 of 1,467) with videos related to

Pageof 147
Sort By:
Annals of the Rheumatic Diseases|April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early diseaseJosef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Lupus Science & Medicine|October 10, 2020
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathwaysThomas Dörner, Yoshiya Tanaka, Michelle A Petri, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Journal of Rheumatology|February 5, 2002
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody contentEng M Tan, Josef S Smolen, J Steven McDougal, et al.
Arthritis Research & Therapy|August 27, 2015
Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritisStephan Blüml, Emine Sahin, Victoria Saferding, et al.
RMD Open|April 10, 2024
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stageAlen Zabotti, Filippo Fagni, Laure Gossec, et al.
Postgraduate Medicine|November 19, 2010
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2Kenneth Blum, Thomas J H Chen, Siobhan Morse, et al.
Annals of the Rheumatic Diseases|August 14, 2020
Infections in baricitinib clinical trials for patients with active rheumatoid arthritisKevin L Winthrop, Masayoshi Harigai, Mark C Genovese, et al.
Cancer Research|April 6, 2006
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesisGromoslaw A Smolen, Beth Muir, Gayatry Mohapatra, et al.
Cell Reports|October 13, 2016
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDHEric L Allen, Danielle B Ulanet, David Pirman, et al.
Pageof 147

Showing results (1261-1270 of 1,467) with videos related to

Sort By:
Pageof 147
Annals of the Rheumatic Diseases|April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early diseaseJosef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Lupus Science & Medicine|October 10, 2020
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathwaysThomas Dörner, Yoshiya Tanaka, Michelle A Petri, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Journal of Rheumatology|February 5, 2002
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody contentEng M Tan, Josef S Smolen, J Steven McDougal, et al.
Arthritis Research & Therapy|August 27, 2015
Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritisStephan Blüml, Emine Sahin, Victoria Saferding, et al.
RMD Open|April 10, 2024
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stageAlen Zabotti, Filippo Fagni, Laure Gossec, et al.
Postgraduate Medicine|November 19, 2010
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2Kenneth Blum, Thomas J H Chen, Siobhan Morse, et al.
Annals of the Rheumatic Diseases|August 14, 2020
Infections in baricitinib clinical trials for patients with active rheumatoid arthritisKevin L Winthrop, Masayoshi Harigai, Mark C Genovese, et al.
Cancer Research|April 6, 2006
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesisGromoslaw A Smolen, Beth Muir, Gayatry Mohapatra, et al.
Cell Reports|October 13, 2016
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDHEric L Allen, Danielle B Ulanet, David Pirman, et al.
Pageof 147